Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT07235527
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 45 and 90 years with active neovascular age-related macular degeneration (nAMD)
* who show signs of disease activity on routine ophthalmologic examination and optical coherence tomography (OCT)
* for whom intravitreal injection has already been clinically indicated
Exclusion Criteria:
* Patients younger than 45 years or older than 90 years
* History of stroke, cerebrovascular event, myocardial infarction, or coronary stent placement within the last six months
* Presence of uveitis
* Media opacity preventing adequate retinal imaging (e.g., corneal opacity, mature cataract)
* Coexistence of other retinal vascular diseases (e.g., branch retinal vein occlusion, diabetic macular edema)
* Presence of hereditary retinal dystrophies
* Presence of optic atrophy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
90 Years
Study:
NCT07235527
Study Brief:
Protocol Section:
NCT07235527